Short answer
RHYTHM PHARMACEUTICALS, INC. (RYTM) filed an 8-K current report with the SEC on June 25, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 92% turnout: 64,146,146 of 69,675,938 eligible votes represented.
RHYTHM PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 92% turnout: 64,146,146 of 69,675,938 eligible votes represented
- David W. J. McGirr and David P. Meeker, MD elected as Class III directors through 2029
- Ernst & Young LLP ratified as independent auditor for year ending December 31, 2026, with 63,924,852 votes FOR
- Executive compensation approved on an advisory basis, with 50,368,659 FOR versus 11,467,157 AGAINST
- Compensation opposition represented approximately 18% of votes cast, a notable shareholder signal despite approval
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other RHYTHM PHARMACEUTICALS, INC. 8-K filings
Get the next RYTM 8-K as it lands
Follow RYTM for push alerts, or ask the research agent what this filing means.